MEETINGS - Emerging Trends & Medicare Policy for Medical Technologies (US) April 2007:
This article was originally published in Clinica
AdvaMed's conference on Emerging Trends & Medicare Policy for Medical Technologies, on April 24-25 in Baltimore, Maryland, will be addressed by acting deputy administrator at the CMS Herb Kuhn, and executive director of MedPAC Mark Miller. New CMS initiatives and their impact on medical technology, policy trends including value-based purchasing and competitive bidding, and the latest developments in Medicare coverage, hospital payment, diagnostics reimbursement and coding will be on the agenda. For details, see: www.advamed.org, or email: email@example.com
You may also be interested in...
Increased fines and penalties are on the cards for manufacturing facilities that fail to comply with proposed new requirements.
The biopharma sector is often accused of a being a slow-moving engine, but a look back over the last 20 years reveals that a lot has changed. In Vivo explores the history of high-impact M&A transactions in the industry between 1999 and 2019.
The Belgian authorities are taking steps to reduce the consumption of benzodiazepine-containing medicines, and have also reiterated the risks associated with the increasing use of opioid medications.